What is Follistatin?
Follistatin is a protein your body produces that binds myostatin and related factors. Because myostatin acts as a “brake” on muscle growth, follistatin’s ability to block it has made it a target of interest for muscle and body-composition research. The honest caveat: the dramatic muscle effects come largely from animal and gene-therapy research, not from the injectable peptide products marketed to consumers, which have limited human data.1
Benefits & what it’s studied for
Animal and gene-therapy research shows increased muscle mass; human peptide data is limited.
Interest in lean mass, but not well-established for the marketed peptide forms.
The impressive findings don’t translate cleanly to the products sold, and human safety data is sparse.
How does Follistatin work?
Follistatin binds myostatin (and activins), preventing them from signaling the muscle to limit growth. Removing that brake is the proposed basis for increased muscle mass.3
Dosing & administration
Marketed forms describe injection. Human dosing is not well-established.4 This is educational, not medical advice. We don’t publish dosing. Any use should be determined by a licensed provider after evaluation.
Risks, side effects & safety
Human safety data is limited. Myostatin inhibition raises theoretical concerns — for example, effects on tendon strength relative to rapid muscle gain, and broader effects of altering a growth-regulating pathway. Medical supervision is essential.5
Legality & status
Follistatin peptide products are not FDA-approved and are not among the peptides addressed in the April 2026 Category 2 removals or the 2026–2027 PCAC dockets. Sourcing and quality vary widely. Off Category 2 ≠ 503A-compoundable ≠ FDA-approved. Confirm with a licensed provider.6 See the full picture in our legality explainer.
Regulatory status as of June 2026 — reconfirm against the live FDA 503A list before go-live.
Thinking about Follistatin?
Talk to a licensed provider who can tell you if it fits your goals — and build a safe protocol.
Research & references
- 1Follistatin / myostatin biology — overview. Link to be finalized. link pending
- 2Myostatin-inhibition / follistatin gene-therapy muscle research (preclinical). Link to be finalized. link pending
- 3Mechanism — follistatin binding of myostatin/activins. Link to be finalized. link pending
- 4Research/marketed dosing literature (not well-established). Link to be finalized. link pending
- 5Follistatin safety / theoretical risk literature. Link to be finalized. link pending
- 6FDA status — not approved; not on April 2026 removals / PCAC dockets. Confirm at publish. link pending
Reference links are illustrative placeholders — replace with verified PubMed/journal URLs before publishing.
Frequently asked questions
What does follistatin do?+
It inhibits myostatin, a protein that limits muscle growth, which is why it’s studied for muscle.
Does follistatin build muscle?+
Animal and gene-therapy research shows muscle increases, but human evidence for the marketed injectable peptides is limited — we grade it Limited.
Is follistatin legal or FDA-approved?+
No, the peptide products aren’t FDA-approved and aren’t among the standard US-compoundable peptides. Confirm status with a provider.
Is follistatin safe?+
Human safety data is sparse, and altering a growth-regulating pathway carries theoretical risks; medical supervision is essential.
Why is the evidence graded Limited?+
Because the dramatic results come from animal/gene-therapy models, not the consumer peptide products.